Juvenile Idiopathic Arthritis
📧 Sign up to get email alerts when something new happens for Juvenile Idiopathic Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-04-19FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab (Remicade) from Janssen Biotech, Inc., updating the product labeling per the supp…
-
FDA approval · 2007-03-29FDA Approved: MELOXICAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for MELOXICAM from Lupin Pharmaceuticals, Inc., indicating regulatory clearance for an updated l…
-
FDA approval · 2007-03-28FDA Approved: MELOXICAM — Supplemental Application (Aurobindo Pharma Limited)
FDA granted a supplemental approval for Meloxicam from Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2007-03-13FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for ORENCIA (abatacept) from E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2007-01-11Clinical Trial Update: Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of growth hormone treatment in Juvenile Idiopathic Arthritis, with completed study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2006-12-25Clinical Trial Update: PRINTO (the Paediatric Rheumatology International Trials Organisation)
Clinical trial update from PRINTO related to Juvenile Idiopathic Arthritis; current status is unknown.
-
FDA approval · 2006-12-20FDA Approved: MELOXICAM — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original ANDA for Meloxicam, manufactured by Unichem Pharmaceuticals (USA), Inc., introducing a generic version of the NSAI…
-
FDA approval · 2006-12-12FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for ORENCIA (abatacept) submitted by E.R. Squibb & Sons, L.L.C., indicating an approved update to th…
-
FDA approval · 2006-12-08FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for infliximab submitted by Janssen Biotech, Inc.
-
FDA approval · 2006-09-26FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., updating the drug's labeling.
-
FDA approval · 2006-09-22FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for tolmetin sodium from Atland Pharmaceuticals, under ANDA074473. This action updates the regulator…
-
FDA approval · 2006-07-28FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited, likely to authorize a new contract manufactur…
-
FDA approval · 2006-07-19FDA Approved: MELOXICAM — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original application for MELOXICAM, a generic meloxicam product. This marks the first generic approv…
-
FDA approval · 2006-07-19FDA Approved: MELOXICAM — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for MELOXICAM from Zydus Pharmaceuticals USA Inc., granting approval for a generic meloxicam product.
-
FDA approval · 2006-07-19FDA Approved: MELOXICAM — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s generic meloxicam under an original ANDA; the approval covers the standard indications for meloxicam (osteoart…